Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Gain Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q1 2024
- Shares held
- 3.04M
- +1.17M (+62.6%) vs. Q1 2024
- Total value
- $3.89M
- −$3.15M (−44.8%) vs. Q1 2024
- New holders
- 8
- 10 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Timelo Investment Management Inc. | 605,288 | $774.8K | 1.56% | +605,288 | New |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $724.6K | 0.04% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 450,000 | $576.0K | 0.00% | +450,000 | New |
| Hohimer Wealth Management, LLC | 330,000 | $422.4K | 0.10% | +330,000 | New |
| Geode Capital Management, LLC | 183,736 | $235.2K | 0.00% | +6,645+3.8% | Added |
| Vanguard Group Inc | 145,217 | $185.9K | 0.00% | +25,853+21.7% | Added |
| Cable Car Capital LLC | 145,000 | $185.6K | 0.20% | +145,000 | New |
| Renaissance Technologies LLC | 118,700 | $151.9K | 0.00% | +72,000+154.2% | Added |
| CM Management, LLC | 90,000 | $115.2K | 0.11% | 00.0% | Unchanged |
| BlackRock Inc. | 84,620 | $108.3K | 0.00% | +9,222+12.2% | Added |
| Warberg Asset Management LLC | 51,600 | $65.5K | 0.02% | +51,600 | New |
| Northern Trust Corp | 44,944 | $57.5K | 0.00% | −1,542−3.3% | Reduced |
| Bridgeway Capital Management, LLC | 40,000 | $51.2K | 0.00% | +10,000+33.3% | Added |
| Prelude Capital Management, LLC | 35,820 | $45.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 34,437 | $44.1K | 0.00% | +3,600+11.7% | Added |
| Virtu Financial LLC | 27,356 | $35.0K | 0.00% | +27,356 | New |
| Millennium Management LLC | 23,373 | $29.9K | 0.00% | −21,043−47.4% | Reduced |
| UBS Group AG | 11,422 | $14.6K | 0.00% | +2,749+31.7% | Added |
| Gilbert & Cook, Inc. | 10,000 | $12.8K | 0.00% | +10,000 | New |
| Simplex Trading, LLC | 9,059 | $11.0K | 0.00% | −8,924−49.6% | Reduced |
| Group One Trading, L.P. | 7,401 | $9.47K | 0.00% | +5,400+269.9% | Added |
| Jones Financial Companies LLLP | 7,000 | $8.96K | 0.00% | +7,000 | New |
| Creekmur Asset Management LLC | 4,440 | $5.68K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,500 | $4.48K | 0.00% | +125+3.7% | Added |
| Morgan Stanley | 3,300 | $4.22K | 0.00% | +500+17.9% | Added |
| Wells Fargo & Company | 2,650 | $3.39K | 0.00% | −1,106−29.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,729 | $2.21K | 0.00% | −2,903−62.7% | Reduced |
| Royal Bank of Canada | 159 | $0 | 0.00% | −248,341−99.9% | Reduced |
| Raymond James & Associates | 0 | $0 | 0.00% | −260,019−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −43,062−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,223−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −684−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |